Taysha Gene Therapies Inc. (TSHA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 96
-0.01
-0.1675%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
2.85M Volume
-0.41 Eps
$ 5.97
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.92 |
| | | - | - |
TSHA Earnings Reports FAQ
What is the earnings per share (EPS) for TSHA?
The current EPS is -0.41.
What is the company's earnings growth rate?
Taysha Gene Therapies Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Taysha Gene Therapies Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Taysha Gene Therapies Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TSHA at this time, as Taysha Gene Therapies Inc has no recent EPS data to calculate it.
